Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems, Kratos to Develop Software for Mass Spectrometers

NEW YORK, March 1 - Proteome Systems said Thursday it had reached an agreement with Kratos Analytical to jointly develop software that would help to further automate Kratos’ AXIMA family of mass spectrometers.

Financial terms were not disclosed.

The deal follows on the heels of a December announcement that Proteome and Kratos’ parent company Shimadzu Biotech would jointly establish proteomics facilities in Sydney, Australia, and Boston. That deal was also an extension of a previous agreement.

The latest announcement is designed to address many of the current bottlenecks in high throughput automation for MALDI applications in proteomics.

The two companies said they would work together to develop software to process information as part of a plan to integrate Proteome Systems sample preparation technologies with the Xcise and Chemical Printer, which was jointly developed by Proteome Systems and Shimadzu, and Kratos’ MALDI-TOF mass spectrometers.

"We are excited to be moving from technology development to high throughput discovery programs based on the combination of Proteome Systems' new instrumentation and the new generation Kratos MALDI mass spectrometers,” Keith Williams, CEO of Proteome Systems, said in a statement. “The final link in this chain is information processing and we are delighted to expand our relationship with Kratos (and Shimadzu) to include this area."

Based in Sydney and Boston, Proteome Systems, develops its own instruments, consumables, and informatics technologies and partners with leading technology companies for the development of proteomics technologies.

Kratos Analytical, of Manchester, UK, is a wholly-owned subsidiary of Japan’s Shimadzu Corporation. Kratos manufactures MALDI-TOF mass spectrometers.

Shimadzu and Proteome Systems have said that they expect to launch their first jointly developed system around August 2001.

Neither company was immediately available for comment.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.